Literature DB >> 21484198

Glutathione pathway gene variation and risk of autism spectrum disorders.

Katherine Bowers1, Qing Li, Joseph Bressler, Dimitrios Avramopoulos, Craig Newschaffer, M Daniele Fallin.   

Abstract

Despite evidence that autism is highly heritable with estimates of 15 or more genes involved, few studies have directly examined associations of multiple gene interactions. Since inability to effectively combat oxidative stress has been suggested as a mechanism of autism, we examined genetic variation 42 genes (308 single-nucleotide polymorphisms (SNPs)) related to glutathione, the most important antioxidant in the brain, for both marginal association and multi-gene interaction among 318 case-parent trios from The Autism Genetic Resource Exchange. Models of multi-SNP interactions were estimated using the trio Logic Regression method. A three-SNP joint effect was observed for genotype combinations of SNPs in glutaredoxin, glutaredoxin 3 (GLRX3), and cystathione gamma lyase (CTH); OR = 3.78, 95% CI: 2.36, 6.04. Marginal associations were observed for four genes including two involved in the three-way interaction: CTH, alcohol dehydrogenase 5, gamma-glutamylcysteine synthetase, catalytic subunit and GLRX3. These results suggest that variation in genes involved in counterbalancing oxidative stress may contribute to autism, though replication is necessary.

Entities:  

Year:  2011        PMID: 21484198      PMCID: PMC3188290          DOI: 10.1007/s11689-011-9077-4

Source DB:  PubMed          Journal:  J Neurodev Disord        ISSN: 1866-1947            Impact factor:   4.025


  42 in total

1.  The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions.

Authors:  D H Geschwind; J Sowinski; C Lord; P Iversen; J Shestack; P Jones; L Ducat; S J Spence
Journal:  Am J Hum Genet       Date:  2001-08       Impact factor: 11.025

2.  Efficiency and power in genetic association studies.

Authors:  Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2005-10-23       Impact factor: 38.330

3.  Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease.

Authors:  Maria Valicenti-McDermott; Kathryn McVicar; Isabelle Rapin; Barry K Wershil; Herbert Cohen; Shlomo Shinnar
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

4.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

Review 5.  Redox control of neural function: background, mechanisms, and significance.

Authors:  Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2006 Nov-Dec       Impact factor: 8.401

6.  Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase.

Authors:  M Koivusalo; M Baumann; L Uotila
Journal:  FEBS Lett       Date:  1989-10-23       Impact factor: 4.124

Review 7.  Autism: recent molecular genetic advances.

Authors:  J A Lamb; J Moore; A Bailey; A P Monaco
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

8.  Examination of association of genes in the serotonin system to autism.

Authors:  B M Anderson; N C Schnetz-Boutaud; J Bartlett; A M Wotawa; H H Wright; R K Abramson; M L Cuccaro; J R Gilbert; M A Pericak-Vance; J L Haines
Journal:  Neurogenetics       Date:  2009-01-28       Impact factor: 2.660

Review 9.  Glutaredoxin systems.

Authors:  Christopher Horst Lillig; Carsten Berndt; Arne Holmgren
Journal:  Biochim Biophys Acta       Date:  2008-06-18

10.  Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration.

Authors:  J Wang; A M Huff; J D Spence; R A Hegele
Journal:  Clin Genet       Date:  2004-06       Impact factor: 4.438

View more
  27 in total

Review 1.  The Putative Role of Environmental Mercury in the Pathogenesis and Pathophysiology of Autism Spectrum Disorders and Subtypes.

Authors:  G Morris; B K Puri; R E Frye; M Maes
Journal:  Mol Neurobiol       Date:  2017-07-22       Impact factor: 5.590

2.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

3.  The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis.

Authors:  Penelope Ae Main; Manya T Angley; Catherine E O'Doherty; Philip Thomas; Michael Fenech
Journal:  Nutr Metab (Lond)       Date:  2012-04-24       Impact factor: 4.169

Review 4.  The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.

Authors:  Scott D Barnett; Iain L O Buxton
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-04-10       Impact factor: 8.250

5.  Hyperexcitability and brain morphological differences in mice lacking the cystine/glutamate antiporter, system xc.

Authors:  Sheila M S Sears; Sarah H Roberts; Sandra J Hewett
Journal:  J Neurosci Res       Date:  2021-11-08       Impact factor: 4.164

Review 6.  Oxidative Stress in Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Mona A El-Bana; Alexey A Tinkov; Khaled Saad; Maryam Dadar; Maha Hemimi; Anatoly V Skalny; Božena Hosnedlová; Rene Kizek; Joško Osredkar; Mauricio A Urbina; Teja Fabjan; Amira A El-Houfey; Joanna Kałużna-Czaplińska; Paulina Gątarek; Salvatore Chirumbolo
Journal:  Mol Neurobiol       Date:  2020-02-05       Impact factor: 5.590

7.  Glutathione S-Transferase Polymorphisms and Clinical Characteristics in Autism Spectrum Disorders.

Authors:  Vanja Mandic-Maravic; Marija Mitkovic-Voncina; Marija Pljesa-Ercegovac; Ana Savic-Radojevic; Miroslav Djordjevic; Marko Ercegovac; Tatjana Pekmezovic; Tatjana Simic; Milica Pejovic-Milovancevic
Journal:  Front Psychiatry       Date:  2021-06-25       Impact factor: 4.157

8.  Genomics as a Clinical Decision Support Tool: Successful Proof of Concept for Improved ASD Outcomes.

Authors:  Heather Way; Grant Williams; Sharon Hausman-Cohen; Jordan Reeder
Journal:  J Pers Med       Date:  2021-06-24

9.  Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism.

Authors:  Shannon Rose; Stepan Melnyk; Timothy A Trusty; Oleksandra Pavliv; Lisa Seidel; Jingyun Li; Todd Nick; S Jill James
Journal:  Autism Res Treat       Date:  2011-11-24

Review 10.  Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder.

Authors:  Cinzia Signorini; Claudio De Felice; Thierry Durand; Camille Oger; Jean-Marie Galano; Silvia Leoncini; Alessandra Pecorelli; Giuseppe Valacchi; Lucia Ciccoli; Joussef Hayek
Journal:  Oxid Med Cell Longev       Date:  2013-06-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.